ABVC BioPharma, Inc.
ABVCNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $27.10M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.71$3.06
- Volume (live)
- -
- Avg. volume (3M)
- 93.83K
ABVC BioPharma (ABVC) Stock Price & Financial Analysis
ABVC BioPharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.03 - $1.06 |
|---|---|
| 52-Week High | $3.06 |
| 52-Week Low | $0.71 |
| Open | $1.04 |
| Volume (last close) | 22.01K |
| Average Volume (3M) | 93.83K |
| Revenue (TTM) | -795.95K |
|---|---|
| Net Income (TTM) | -7.90M |
| Free Cash Flow (TTM) | -2.94M |
| EPS (TTM) | −$0.32 |
| Return on Equity (ROE) | -76.82% |
| Debt to Equity | 0.22 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 27.10M |
|---|---|
| Shares Outstanding | 26.06M |
| Price to Book (P/B) | 2.63 |
| EV/EBITDA | -3.81 |
| 50-Day MA | $0.97 |
|---|---|
| 200-Day MA | $1.30 |
| 1-Year Change | −64.14% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
ABVC BioPharma at a Glance
As of the Oct 23, 2026 close, ABVC BioPharma (ABVC) has a market capitalization of $27.10M. Over the trailing twelve months it lost $7.90M on revenue of −$795.95K and burned $2.94M of free cash flow. Revenue fell 303.4% year over year.
As of its latest reported balance sheet, it holds $31.94K in cash and securities against $2.26M of debt, a net debt position of $2.23M.
ABVC BioPharma does not currently pay a dividend.
The share price is down 64.1% over the past year. At $1.04 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.71 to $3.06, below its 200-day moving average of $1.30.
Frequently Asked Questions About ABVC BioPharma
What is the current stock price for ABVC?
As of the Oct 23, 2026 close, ABVC stock trades at $1.04. The 52-week range is $0.71–$3.06, with a day range of $1.03–$1.06.
What is the P/E ratio for ABVC?
The P/E ratio (Price-to-Earnings) for ABVC is shown in the Key Statistics section. This valuation metric helps compare ABVC BioPharma, Inc. to industry peers.
Does ABVC pay dividends?
ABVC BioPharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ABVC?
Analyst ratings and recommendations for ABVC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ABVC?
As of the Oct 23, 2026 close, ABVC BioPharma's market capitalization is $27.1M, classifying it as a micro-cap company. ABVC BioPharma operates in the Healthcare sector within the Biotechnology industry.